Mobile Site ›
Print Friendly View

Test ID: HL58O    
HLA-B*5801 Genotype, Allopurinol Hypersensitivity, Saliva

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Conditional

Useful For Suggests clinical disorders or settings where the test may be helpful

Predicting increased risk of hypersensitivity reactions to allopurinol

 

Excluding patients at an elevated risk for allopurinol hypersensitivity syndrome from receiving allopurinol

 

Genotyping patients who prefer not to have venipuncture done

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Qualitative allele-specific real-time Polymerase Chain Reaction (PCR)

(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.) 

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

HLA-B 5801, Allopurinol, Saliva

Aliases Lists additional common names for a test, as an aid in searching

Allopurinol Hypersensitivity Syndrome (AHS)
Lesch-Nyhan Syndrome
Gout
Stevens-Johnson Syndrome
Toxic Epidermal Necrolysis
Urate Kidney Stones